Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA07010682 3-Methylbutyl octanoate 3-Methylbutyl octanoate WE 13:0 C13H26O2 214.193280
LMFA07090013 FAHFA 18:0/10O(FA 18:0) 10-octadecanoyloxy-octadecanoic acid FAHFA 36:0;O C36H70O4 566.527411
LMFA13010050 2-O-(beta-D-galactopyranosyl-(1->6)-beta-D-galactopyranosyl) 2S,3R-dihydroxyundecanoic acid 2-O-(beta-D-galactopyranosyl-(1->6)-beta-D-galactopyranosyl) 2S,3R-dihydroxyundecanoic acid C23H42O14 542.257461
LMFA13030005 3-O-(alpha-L-rhamnopyranosyl-(1-2)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoyl-3-hydroxydecanoic acid 3-O-(alpha-L-rhamnopyranosyl-(1-2)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoyl-3-hydroxydecanoic acid C32H58O13 650.387746
LMFA13010042 Ethyl 3-O-beta-D-glucopyranosyl-butanoate Ethyl 3-O-beta-D-glucopyranosyl-butanoate C12H22O8 294.131470
LMFA03060105 16-HETE (5Z,8Z,11Z,14Z)-16-hydroxyicosa-5,8,11,14-tetraenoic acid FA 20:4;O C20H32O3 320.235146
LMFA03060105 16-HETE (5Z,8Z,11Z,14Z)-16-hydroxyicosa-5,8,11,14-tetraenoic acid FA 20:4;O C20H32O3 320.235146
LMFA03060105 16-HETE (5Z,8Z,11Z,14Z)-16-hydroxyicosa-5,8,11,14-tetraenoic acid FA 20:4;O C20H32O3 320.235146
LMFA01160020 keto meromycolic acid 2-{1-hydroxy-15-[2-(19-methyl-18-oxooctatriacontyl)cyclopropyl]pentadecyl}tetracosanoic acid FA 81:2;O2 C81H158O4 1195.216013
LMFA01160020 keto meromycolic acid 2-{1-hydroxy-15-[2-(19-methyl-18-oxooctatriacontyl)cyclopropyl]pentadecyl}tetracosanoic acid FA 81:2;O2 C81H158O4 1195.216013
LMFA01160020 keto meromycolic acid 2-{1-hydroxy-15-[2-(19-methyl-18-oxooctatriacontyl)cyclopropyl]pentadecyl}tetracosanoic acid FA 81:2;O2 C81H158O4 1195.216013
LMFA01160020 keto meromycolic acid 2-{1-hydroxy-15-[2-(19-methyl-18-oxooctatriacontyl)cyclopropyl]pentadecyl}tetracosanoic acid FA 81:2;O2 C81H158O4 1195.216013
LMFA01160020 keto meromycolic acid 2-{1-hydroxy-15-[2-(19-methyl-18-oxooctatriacontyl)cyclopropyl]pentadecyl}tetracosanoic acid FA 81:2;O2 C81H158O4 1195.216013
LMFA08010021 glutaramic acid 5-amino-5-oxopentanoic acid C5H9NO3 131.058244
LMFA01050476 2-dehydro-3-deoxy-L-arabinonic acid 3-deoxy-L-pent-2-ulosonic acid FA 5:1;O3 C5H8O5 148.037175
LMFA01050476 2-dehydro-3-deoxy-L-arabinonic acid 3-deoxy-L-pent-2-ulosonic acid FA 5:1;O3 C5H8O5 148.037175
LMFA01050488 3,4-dihydroxy-4-methylhexadecanoic acid 2,5-dideoxy-4-C-dodecylpentonic acid FA 17:0;O2 C17H34O4 302.245711
LMFA01050488 3,4-dihydroxy-4-methylhexadecanoic acid 2,5-dideoxy-4-C-dodecylpentonic acid FA 17:0;O2 C17H34O4 302.245711
LMFA01050454 (R)-2-ethylmalic acid (2R)-2-ethyl-2-hydroxybutanedioic acid FA 6:1;O3 C6H10O5 162.052825
LMFA01050454 (R)-2-ethylmalic acid (2R)-2-ethyl-2-hydroxybutanedioic acid FA 6:1;O3 C6H10O5 162.052825
LMFA07070080 Malonylcarnitine (3S)-3-[(2-carboxyacetyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 3:1;O2 C10H17NO6 247.105589
LMFA07010868 Ethyl 4-decenoate ethyl (4E)-dec-4-enoate SFE 12:1 C12H22O2 198.161980
LMFA07010868 Ethyl 4-decenoate ethyl (4E)-dec-4-enoate SFE 12:1 C12H22O2 198.161980
LMFA07010876 Ethyl hydrogen fumarate (2Z)-4-ethoxy-4-oxobut-2-enoic acid SFE 6:2;O2 C6H8O4 144.042260
LMFA07010876 Ethyl hydrogen fumarate (2Z)-4-ethoxy-4-oxobut-2-enoic acid SFE 6:2;O2 C6H8O4 144.042260
LMFA07010988 Pentyl 3-methylbutanoate pentyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07010988 Pentyl 3-methylbutanoate pentyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07070016 (2E,5Z,7E)-decatrienoylcarnitine 3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:3 C17H27NO4 309.194009
LMFA07070016 (2E,5Z,7E)-decatrienoylcarnitine 3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:3 C17H27NO4 309.194009
LMFA07070033 2-Hydroxymyristoylcarnitine 3-[(2-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070033 2-Hydroxymyristoylcarnitine 3-[(2-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07010965 methyl oleate methyl (9Z)-octadec-9-enoate SFE 19:1 C19H36O2 296.271531
LMFA07010965 methyl oleate methyl (9Z)-octadec-9-enoate SFE 19:1 C19H36O2 296.271531
LMFA07010954 Methyl 4-pentenoate methyl pent-4-enoate SFE 6:1 C6H10O2 114.068080
LMFA07010954 Methyl 4-pentenoate methyl pent-4-enoate SFE 6:1 C6H10O2 114.068080
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA02030026 ent-9-B1-PhytoP (R,E)-11-(2-ethyl-5-oxocyclopent-1-en-1-yl)-9-hydroxyundec-10-enoic acid FA 18:4;O2 C18H28O4 308.198761
LMFA04020371 (10R,13R,16R)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645